Entity type
Company
Filer Snapshot
BRISTOL MYERS SQUIBB CO
CIK 0000014272. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
309
Latest filing
05 May 2026
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13D/G stake for CGEN. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
CGEN
31 Dec 2024 · 2.1% ownership
Open 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 05 May 2026 for CIK 0000014272.
- Trading symbols
- BMY, CELG-RI on NYSE
- SEC ownership summary
-
Schedule 13G holdings
Large-stake holdings reported on parsed Schedule 13G filings.
CGEN QTTB CELUHow to read these values
- Filing families stay separate: 13F portfolio value, 13D/G large stakes, and Forms 3/4/5 owner positions should not be blended into one total.
- Use the linked research paths to verify each signal against the original SEC filing.
- Business address
- Route 206 And Province Line Road, Princeton, NJ, 08543
- State of incorporation
- DE
- Fiscal year-end
- 31 December
SEC ownership signals
1 fact
Filer identity
2 facts
SEC record
2 facts
Filer intelligence
What SEC filings say about BRISTOL MYERS SQUIBB CO
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- 3 recent 13D/G stake rows found; top row is CGEN at 2.1% ownership.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13D/G large-stake context
CGEN
31 Dec 2024 · Ordinary Shares, par value NIS 0.01
CELU
31 Dec 2024 · Class A Common stock, par value $0.0001 per share
QTTB
31 Dec 2024 · Common stock, par value $0.0001 per share
Latest update
What changed recently for BRISTOL MYERS SQUIBB CO
Latest financial period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
30 Apr 2026
Page type
Company facts
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 30 Apr 2026.
Benchmark Context
Benchmark context for this company
BRISTOL MYERS SQUIBB CO has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 30 Apr 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0000014272 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
309
First seen
07 May 2021
Latest filing
05 May 2026
Entity
Company
Observed form types
10-K
10-Q
3
3/A
4
5
SCHEDULE 13G/A
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 309 SEC filings for BRISTOL MYERS SQUIBB CO.
4
4 filing
- Filing date
- 05 May 2026
- Reporting date
- 01 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
10-Q filing
- Filing date
- 30 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 12 Mar 2026
- Reporting date
- 10 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 12 Mar 2026
- Reporting date
- 10 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 12 Mar 2026
- Reporting date
- 10 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing